FDA Enforcement Class I Terminated

JELCO HYPODERMIC NEEDLE-PRO FIXED NEEDLE INSULIN SYRINGE: a) 1.0mL 28G X 1/2" (0.33mm x 13mm), REF 4428-1 b) 1.0mL 29G X 1/2" (0.33mm x 13mm), REF 4429-1

Recall: Z-1798-2021 · Reported June 16, 2021

Enforcement

Recall Number
Z-1798-2021
Event ID
87945
Classification
Class I
Status
Terminated
Product Type
Devices
Firm
Smiths Medical ASD Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
E-Mail
Report Date
June 16, 2021
Initiation Date
May 17, 2021
Classification Date
June 10, 2021
Termination Date
October 11, 2023
Address
6000 Nathan Ln N, N/A, Minneapolis, MN, 55442-1690, United States

Description

JELCO HYPODERMIC NEEDLE-PRO FIXED NEEDLE INSULIN SYRINGE: a) 1.0mL 28G X 1/2" (0.33mm x 13mm), REF 4428-1 b) 1.0mL 29G X 1/2" (0.33mm x 13mm), REF 4429-1

Reason

Specific models and lot numbers of the Jelco Hypodermic Needle-Pro Fixed Needle Insulin Syringe 29Gx1/2 odd number line graduation markings on the syringe barrel were skewed approximately 20 degrees upward.

Code Info

a) REF 4428-1, Lot Numbers: 4046543 and 4062235 b) REF 4429-1, Lot Numbers: 4031846, 4031845, 4040734, 4043536, 4046545, 4046546, 4062239, 4062240, 4062238, 4062242, 4014096

Distribution

Worldwide distribution - US Nationwide and the countries of UK, Spain.

Quantity

1,432,200 units